Bio-identical Hormone & Peptide Specialists

Table of Contents
Cardio Res-Q Assessment from $775

Advanced labs, the Cleveland Heart panel and Dr. Varano’s evaluation:

Autoimmune Disease and Heart Risk: Rheumatoid Arthritis, Lupus and Psoriasis

Autoimmune Disease and Heart Risk: Rheumatoid Arthritis, Lupus and Psoriasis

Rheumatoid arthritis, lupus, psoriasis and other autoimmune diseases raise the risk of heart attack and stroke. The increase is separate from the usual causes such as cholesterol and blood pressure, and it tends to show up at younger ages than people expect.

Standard heart risk calculators have no input for autoimmune disease, so the number they produce can be too low. If you have one of these conditions, the estimate deserves a second look and the ordinary risk factors deserve closer attention.

Key takeaways

  • Across 19 autoimmune diseases, a large UK study found cardiovascular disease was roughly one and a half times as common as in matched people without them.
  • The relative increase is greatest in younger adults and grows with each additional autoimmune condition.
  • General risk calculators mostly underestimate risk in people with rheumatic disease, and attempts to adjust them have not worked well.
  • US cholesterol guidance has treated chronic inflammatory conditions as factors that push a borderline estimate upward.

How large is the added risk?

The broadest evidence is a 2022 study in The Lancet that drew on the health records of 22 million people in the UK. It identified 446,449 people newly diagnosed with any of 19 autoimmune diseases and compared them with more than 2.1 million matched people without one.

Over a median of 6.2 years, cardiovascular disease developed at a rate 56% higher in the autoimmune group.1 The risk rose with the number of conditions: 41% higher with one autoimmune disease, more than two and a half times as high with two, and nearly four times as high with three or more.

Age mattered too. Among people younger than 45, cardiovascular disease was more than twice as common in those with an autoimmune disease, while at 75 and older the difference narrowed to 30%.1 Heart disease is still less common in younger adults overall. The point is that an autoimmune diagnosis removes some of the protection that youth normally provides.

Rheumatoid arthritis, lupus and psoriasis

These three conditions have been studied the most.

Rheumatoid arthritis. A meta-analysis of 14 studies covering 41,490 patients found a 48% higher risk of new cardiovascular disease in people with rheumatoid arthritis than in the general population, including a 68% higher risk of heart attack.2

Lupus. In the UK study, systemic lupus erythematosus carried one of the highest risks of any condition examined, at nearly three times the rate of cardiovascular disease seen in matched controls.1 Systemic sclerosis, Addison's disease and type 1 diabetes were the others at the top of the list.

Psoriasis. Risk tracks with severity. In a meta-analysis of nine studies, mild psoriasis was associated with a 29% higher risk of heart attack, and severe psoriasis with a 70% higher risk of heart attack and a 39% higher risk of cardiovascular death.3 The authors cautioned that the studies adjusted for other risk factors to different degrees.

Why inflammation matters

Atherosclerosis is partly an inflammatory process, and autoimmune diseases keep the immune system active for years. That is the leading explanation for the added risk. We cover the biology in our guide to inflammation and heart disease, so it is not repeated here.

Treatment plays a part as well. European rheumatology recommendations advise keeping disease activity under control and keeping steroid doses as low as possible in lupus and vasculitis, as part of managing cardiovascular risk.4 Those are decisions for your rheumatologist. Do not start, stop or change a medication without your prescriber.

Why calculators underestimate

Risk calculators such as PREVENT are built from age, blood pressure, cholesterol, diabetes, smoking and kidney function. Autoimmune disease is not one of the inputs, so two people with identical numbers get the same estimate even if one has had rheumatoid arthritis for 15 years.

A systematic review of studies that tested these tools in people with rheumatic diseases concluded that general risk algorithms mostly underestimate, and at times overestimate, cardiovascular risk in these patients.5 Attempts to fix the problem with multipliers or disease-specific variables largely failed to improve the estimates in rheumatoid arthritis and lupus.

For lupus and several other rheumatic diseases, European recommendations still advise using the general tools, because no validated disease-specific tool exists.4 The estimate is then interpreted with the diagnosis in mind.

US guidance has handled this through the idea of risk enhancers. The 2018 US cholesterol guideline named chronic inflammatory disorders, with rheumatoid arthritis and psoriasis as examples, among the risk-enhancing factors that favor treatment when a calculated risk is intermediate.6

What gets checked

  • The standard risk factors. Blood pressure, a lipid panel, blood sugar and smoking status matter at least as much as in anyone else.
  • A calculated risk estimate. It is read with your diagnosis in mind, because it may run low.
  • Inflammation markers, with care. A raised hs-CRP may reflect the autoimmune disease itself, which makes it harder to read as a heart signal. See our guide to causes of a high hs-CRP.
  • Imaging in selected cases. When the estimate is uncertain, a coronary calcium score is one test clinicians use to look for plaque directly.

Your disease history is part of the assessment too: how long you have had the condition, how active it has been and which medications you have taken.

Your next step

If you have an autoimmune disease and no one has reviewed your heart risk, raise it at your next visit and make sure the clinician knows your diagnosis when reading the estimate. Bring your recent blood pressure readings and lipid results.

You can also answer the three quick questions in the screener on the Cardio Res-Q program page. Autoimmune conditions such as arthritis and psoriasis are among the risk factors listed on that page.

Cardiovascular Risk Screener

Are You a Candidate for Cardio Res-Q?

Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.

Frequently asked questions

Does treating my autoimmune disease lower my heart risk?

Controlling disease activity is part of what European recommendations advise for managing cardiovascular risk. The same recommendations note that no particular immunosuppressive treatment in lupus has been shown to lower cardiovascular risk. Good disease control and attention to standard risk factors go together, and neither replaces the other.

Which autoimmune diseases carry the highest heart risk?

In the large UK study of 19 conditions, systemic sclerosis, Addison's disease, lupus and type 1 diabetes had the highest overall cardiovascular risk. Every condition studied showed some increase, and having more than one raised the risk further.

My calculated heart risk is low. Can I rely on it?

Treat it as a starting point. The calculators do not account for autoimmune disease, and studies show they mostly underestimate risk in people with rheumatic conditions. Ask your clinician how your diagnosis changes the reading of your number.

Related reading

This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.

Optimize Your Health Today!

Cardio Res-Q starts with the $775 Comprehensive or $999 Enhanced Assessment, led by Dr. Varano.

age management doctor philadelphia
Send Us A Message
About Dr. Kenneth Varano, D.O.
age management doctor philadelphia

YoungerMeMD is a physician-led practice in Anti-Aging, Functional and Preventive Medicine, and your care is delivered by our whole clinical team. That team works under Medical Director Kenneth Varano, D.O., who brings over 30 years in clinical medicine and more than 20 years in age management and functional medicine — using science-backed, patient-focused strategies that restore balance, vitality, and health longevity.

About Barbara Dougherty
anti aging treatments

Barbara Dougherty, MSN, CRNP, is a Board-Certified Family Nurse Practitioner and Certified Menopause Practitioner (MSCP) specializing in optimizing hormones, and improving cardio-metabolic health. 

Read Our Reviews

“I’ve been seeing Dr. Varano for just over a year now, and I don’t think I’ve been this healthy and energetic since grade school.

Transform Your Health Today

Ready to take the first step toward renewed energy, balance, and longevity? New patients can register for an initial evaluation to begin their personalized anti-aging journey with YoungerMe MD. Live Younger. Better. Longer. — with YoungerMe MD.

References

  1. Conrad N, et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet 2022. PMID 36041475 · doi:10.1016/S0140-6736(22)01349-6↩
  2. Avina-Zubieta JA, et al. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2012. PMID 22425941 · doi:10.1136/annrheumdis-2011-200726↩
  3. Armstrong EJ, et al. Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc 2013. PMID 23557749 · doi:10.1161/JAHA.113.000062↩
  4. Drosos GC, et al. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis 2022. PMID 35110331 · doi:10.1136/annrheumdis-2021-221733↩
  5. Colaco K, et al. Predictive Utility of Cardiovascular Risk Prediction Algorithms in Inflammatory Rheumatic Diseases: A Systematic Review. J Rheumatol 2020. PMID 31416923 · doi:10.3899/jrheum.190261↩
  6. Grundy SM, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019. PMID 30586774 · doi:10.1161/CIR.0000000000000625↩
Book a Discovery Call Peptide Consult
Close
Book a Discovery Call
Close
Peptide Consult







    Transform Your
    Health & Wellness

    Fill up the form below to get started

      Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.

      Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.

      DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.

      Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.

      Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.

      Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.

      Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.

      Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.

      What It Evaluates

      Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:

      Conditions We Identify